Clinical Trial Update: Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial is evaluating a microbial therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Recruitment is ongoing as the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• MASLD microbial therapy (investigational)

Snippet

Sponsor: Leeuwenhoek Laboratories Co. Ltd. | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease | Phase 1 | Status: RECRUITING